56% of Covid-19 patients with secondary infection die: ICMR study

Many patients needed potent antibiotics as they had superbugs and couldn't be treated with regular ones.

More than half of Covid-19 patients who develop a secondary bacterial or fungal infection die in India, said a study by a state-run institute that the 'Times of India' quoted on Friday.

Indian Council of Medical Research’s (ICMR) studied patients with secondary infections admitted in intensive care units (ICUs) and wards of 10 hospitals between June and August 2020.

According to its study, some Covid-19 patients develop a secondary bacterial or fungal infection during or after Covid-19 treatment. Out of the 17,534 patients studied, 3.6% developed a secondary bacterial or fungal infection and the mortality among these patients was 56.7%.

The drug-resistant variants